⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

March 11, 2014Scandinavian Journal of RheumatologyOpen Access

Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen

FC Moazedi-Fuerst SM Kielhauser Kerstin Brickmann Josef Hermann A. Lutfi Michael Meilinger HP Brezinschek W. Graninger

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Systemic sclerosis (SSc) can be a devastating disease with lethal complications such as interstitial lung disease (ILD). Therapeutic strategies include cyclophosphamide but patients are frequently ...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Moazedi-Fuerst et al. (2014) studied this question.

synapsesocial.com/papers/6a8bc95590fae8fd47e992df https://doi.org/10.3109/03009742.2013.869617

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosisPilot Study · 2009 · 297 citations
2Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyOriginal Research · 2009 · 394 citations
3Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisRCT · 2004 · 2,627 citations
4Adenosine deaminase-2 (ADA2) enzymatic activity refines interpretation of a heterozygous ADA2 variant in familial Mediterranean fever-associated cutaneous polyarteritis nodosaScandinavian Journal of Rheumatology · 2026
5Guselkumab resolved refractory Crohn’s disease-associated peritendinous inflammation documented by serial ultrasonography and magnetic resonance imagingScandinavian Journal of Rheumatology · 2026
6Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 studyScandinavian Journal of Rheumatology · 2026
7Colchicine for hypergammaglobulinaemic purpura of Waldenström in Sjögren’s disease: a case seriesScandinavian Journal of Rheumatology · 2026
8Diagnostic utility of the HAS-GCA score versus other Southend Giant Cell Arteritis Probability Score–ultrasound prediction models in giant cell arteritisScandinavian Journal of Rheumatology · 2026
9Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort studyScandinavian Journal of Rheumatology · 2026
10Risk of peripheral artery disease following ankylosing spondylitis, 2012–2023: a nationwide cohort study in South KoreaScandinavian Journal of Rheumatology · 2026

More from Scandinavian Journal of Rheumatology

More from Medical University of Graz

More from University of Graz